An observational study in Enhanced Recovery After Surgery, Perioperative Care and Surgical Care, sponsored by Universidad de Zaragoza. Not yet recruiting at 1 site in Spain. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-29.
Sponsored by Universidad de Zaragoza · Observational
RIDECLAS is an observational, prospective, non-interventional consensus study using a modified Delphi methodology. The study aims to obtain expert consensus on the classification and final formulation of recommendations for the RICA Pathway, an enhanced recovery pathway for adult surgery. Participants will be healthcare professionals with experience in enhanced recovery, perioperative medicine, surgery, anesthesiology, nursing, rehabilitation, or related disciplines. Experts will complete sequential online questionnaires. Individual responses will remain confidential, and aggregated anonymized feedback will be provided between Delphi rounds. The study does not involve patients, clinical interventions, biological samples, drugs, or medical devices.
This study will use a modified Delphi process conducted remotely through electronic questionnaires. A coordinating committee will prepare an initial list of recommendations based on the previous RICA Pathway document and updated evidence. Expert panelists will rate each recommendation using a 1-to-9 Likert scale and may provide free-text comments. Two Delphi rounds are planned, with a third round if needed for items without sufficient consensus or for reformulated statements. Between rounds, participants will receive aggregated and anonymized feedback, including measures of agreement, median scores, dispersion, and a summary of comments. Consensus for acceptance is predefined as at least 75% of ratings in the 7-9 range and no more than 15% in the 1-3 range. Consensus for rejection is predefined as at least 75% of ratings in the 1-3 range and no more than 15% in the 7-9 range. Items not meeting consensus criteria may be reassessed in subsequent rounds. The analysis will be descriptive and will include response rates, attrition between rounds, item-level agreement, median scores, interquartile ranges, and qualitative thematic review of comments.
Universidad de Zaragoza is the lead sponsor of 111 studies on the registry; 18 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study population will consist of healthcare professionals and scientific society members with experience in enhanced recovery pathways, perioperative medicine, surgery, anesthesiology, nursing, rehabilitation, or related disciplines. Participants will be invited from the Grupo Español de Rehabilitación Multimodal (GERM) and related professional networks.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
At least 5 years of professional experience. Membership in GERM or participation in professional networks related to enhanced recovery in adult surgery.
Willingness to participate in the planned Delphi rounds. Provision of electronic .
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Healthcare professionals with experience in enhanced recovery pathways, perioperative medicine, surgery, anesthesiology, nursing, rehabilitation, or related disciplines who are invited to participate in the modified Delphi process.
Other: Modified Delphi questionnaire
Sequential online questionnaires used to rate and classify proposed RICA Pathway recommendations. This is not a clinical intervention and does not involve patient care, drugs, devices, or invasive procedures.
Expert consensus on RICA Pathway recommendations
Consensus will be assessed for each recommendation using predefined Delphi criteria. Acceptance consensus will be defined as at least 75% of ratings in the 7-9 range and no more than 15% in the 1-3 range. Rejection consensus will be defined as at least 75% of ratings in the 1-3 range and no more than 15% in the 7-9 range.
Time frame: Through study completion, up to 7 months
Degree of agreement for each recommendation
Distribution of ratings, median score, interquartile range, and percentage of ratings in predefined agreement/disagreement ranges.
Time frame: After each Delphi round, up to 7 months.
Stability of ratings between Delphi rounds
Descriptive assessment of changes in item-level ratings and consensus status between rounds.
Time frame: Between round 1 and round 2, and round 3 if performed, up to 7 months.
Response rate and attrition between rounds
Number and percentage of invited experts who complete each round, and percentage lost between rounds.
Time frame: After each Delphi round, up to 7 months.
Qualitative analysis of expert comments
Thematic review of free-text comments to support item reformulation and interpretation of items without consensus.
Time frame: After each Delphi round, up to 7 months.
Plan to share: No — Individual participant data will not be shared. This is a modified Delphi consensus study involving expert panelists rather than patients. Individual responses will be treated confidentially, stored in coded form, and analyzed and reported only in aggregate. Sharing individual-level responses could compromise participant confidentiality and may affect the independence of expert judgment in the Delphi process. Aggregated results, consensus levels, and methodological details will be reported in the final publication.
This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.